A few updates for you this week, including approval of Hemgenix for Hemophilia B, Rebyota for CDiff inflection, and Rezlidhia for refractory AML. Don’t forget to like, share, & subscribe! ENJOY!

A few updates for you this week, first the FDA approved Tzield to delay the progression of type 1 diabetes - a big advancement for the treatment of type 1 diabetes. The FDA also approved another biosimilar to Lantus, called Rezvoglar and issued a new EUA for Kineret for COVID-19 treatment. Don’t forget to like, share, & subscribe! ENJOY!

Just two updates for you this week, first a review of the current situation regarding what the media has labeled as the “tripledemic” and a warning issued by the FDA related to certain illicit medications being laced with other sedatives. Don’t forget to like, share, & subscribe! ENJOY!

Two updates from the FDA this week, approvals for both Tecvayli for multiple myeloma and Imjudo for liver cancer. Don’t forget to like, share, & subscribe! ENJOY!

Two updates that I saw from the FDA this week, an updated EUA for the Pfizer and Moderna Bivalent COVID19 Vaccines, and a statement from the FDA on the current shortage of amphetamine salts. Don’t forget to like, share, & subscribe! ENJOY!

Just two quick updates from the FDA this week, a new indication for Boostrix and updated Facts Sheet for Evusheld after some not so promising results with the new Omicron variant. Don’t forget to like, share, & subscribe! ENJOY!

So we have a few things to review this week - first the FDA issuing a warning against some odd and potentially dangerous social media challenges which have been coming up. And then we have approval or updates from 3 products - Skysona, Retevmo, & Relyvrio. Don’t forget to like, share, & subscribe! ENJOY!

So we have a short episode this week, just 2 things to go over from the FDA today, including the approval of Spevigo for GPP flares and approval of Daxxify as a competitor to Botox Cosmetic. Don’t forget to like, share, & subscribe! ENJOY!

We’ve just got a couple things to talk about - first with some updated COVID19 information and then approval of Xenpozyme - the first drug to treat Acid Sphingomyelinase Deficiency. Don’t forget to like, share, & subscribe! ENJOY!

In today’s episode, lots of COVID19 updates including Pfizer and Moderna new Omicron booster, an EUA for Novavax vaccine for kids as young as 12, approval of single dose COMIRNATY, and updated interaction check guidelines for Paxlovid. The FDA also approved rapid-acting Auvelity for major depression and expanded use of Omnipod 5 for younger children. Don’t forget to like, share, & subscribe! ENJOY!